Why I Can't Stop Buying This “Boring” Chipmaker With Game Changing Upside

Broadcom’s AI semiconductor revenue surged to $10.80B in Q2 FY2026 (+143% YoY), and management guided Q3 AI revenue to $16B (+200% YoY). Full-year 2026 AI revenue is targeted at $56B and fiscal 2027 at $100B+, with Q2 AI bookings of $30B+ vs $10.8B shipped and visibility extending into 2028. Financial quality improved as Q2 FCF reached $10.26B (46% of revenue) and adjusted EBITDA margin held at 69%, while Broadcom raised its dividend 10% to $0.65/share and authorized a fresh $10B buyback (with $7.8B deployed in Q1).

Analysis

AVGO is increasingly a cash-flow instrument on hyperscaler capex rather than a cyclical semiconductor name. The second-order benefit is that its custom silicon plus networking stack should take share exactly where customers are most motivated to economize versus merchant GPUs: inside large, repeatable AI buildouts. That creates a favorable mix shift for AVGO versus NVDA and, to a lesser extent, MRVL, because the economic buyer is optimizing total cluster cost and power efficiency, not just benchmark performance.

The market should also think about the supply-chain winner: if AI deployments are being locked in through 2028, long-lead component orders can pull forward substrate, packaging, optics, and datacenter interconnect demand. That is supportive for select infrastructure names, but it also raises the risk that the AI trade becomes more about execution cadence than headline TAM; any slippage in customer ramp timing would hit AVGO harder than a merchant-chip pure play because the stock now prices in very high visibility.

Near term, the risk is crowded positioning and multiple sensitivity. The setup can stay strong for months if bookings keep converting, but the stock can correct sharply on any sign that bookings are front-loaded, customer concentration is narrowing, or hyperscaler capex is flattening. The contrarian view is that "visibility into 2028" may simply mean large customers are negotiating supply now; that is positive for revenue certainty, but it also caps pricing power over time. The thesis breaks if AI revenue guide momentum slows for even one quarter or if consensus starts discounting FY27-28 growth as too linear.

Key Decisions for Investors

• Maintain a core long AVGO, but add only on 5-8% pullbacks; the setup is strongest when the market gives a better entry because the stock is already crowded and sensitive to any guide miss.
• Pair trade: long AVGO / short MRVL over 1-3 months. AVGO has better backlog-to-cash-flow conversion and stronger pricing power in custom AI infrastructure; MRVL is more exposed to the market re-rating networking/ASIC spend as less differentiated.
• If keeping semis exposure broad, prefer AVGO over NVDA for the next earnings window: AVGO monetizes the buildout regardless of which GPU architecture wins, while NVDA is more exposed to digestion risk after hyperscalers secure custom alternatives.
• Use upside call spreads rather than outright stock for a 3-6 month view if position sizing is constrained; implied volatility is likely to stay supported, and the risk is a sharp de-rating if capex cadence decelerates.
• Set a watch item on hyperscaler capex commentary from GOOGL and META over the next 1-2 quarters; any reduction in AI infrastructure spend would be the fastest falsifier for AVGO's 2027-2028 visibility thesis.